🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Spain / NCT06296979
Recruiting Not applicable

Effectiveness of Noninvasive Phrenic Nerve Neuromodulation in Shoulder Pain and Hepatobiliary Visceral Comorbidity.

NCT06296979 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2024-03-20
Last updated
2025-04-02

Condition(s) studied

Shoulder Pain

Investigational drug(s) / intervention(s)

Phrenic nerve neuromodulationcommon Physical therapy

Phrenic nerve neuromodulation: The intervention group will receive the usual physiotherapy treatment at the health center and will also receive neuromodulation on the phrenic nerve at its exit through the anterior cervical region. The neuromodulation technique will be applied for 10 minutes.

common Physical therapy: the usual treatment of the center consisting of manual therapy, exercise and thermotherapy will be performed.

Study summary

Pain, particularly shoulder pain, is a social and economic problem worldwide. Although visceral pathology is not yet taken into account in the diagnosis of these pains, it is likely that on numerous occasions the hepatobiliary visceral condition causes referred pain in the metameric area belonging to the shoulder due to the involvement of the phrenic nerve. Therefore, the aim of this project is to study the response of treatment by neuromodulation of the phrenic nerve for shoulder pain in patients with associated hepatobiliary pathologies, assessing the possible visceral involvement in the symptomatology.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Over 18 years of age. * Subjects presenting right shoulder pain at the time of enrollment in the study. * Presentation of a hepatobiliary visceral disorder that may justify the visceral etiology of the pain. * That they agree to participate in the project by signing the informed consent form. Exclusion Criteria: * Patients with chronic pain due to other diseases such as malignant disease. * Patients with rheumatic diseases. * Cutaneous infection in the area of pain. * Disease of neurological, traumatic, oncologic, or infectious origin that rules out the visceral origin of the pain. * Uncooperative subject. * Severe psychiatric disease. * Loss of cognitive capacity. * Contraindication to electrotherapy.

Primary outcome measure(s)

Trial sites (4)

FacilityCityRegionStatus
Centro de Salud Ronda Histórica Seville Sevilla Recruiting
Centro de Salud las Letanías Seville Sevilla Recruiting
Centro de Salud Bellavista Seville sevilla Recruiting
Centro de especialidades Morón de la Frontera Morón de la Frontera Seville Recruiting

More University of Seville trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06296979 on ClinicalTrials.gov ↗ ← All trials in Spain